Exploring the combined role of genetic and non-genetic factors that lead to AMD: a system-level analysis of disease subgroups, risk factors and pathways



This proposal will exploit existing longitudinal cohort studies from the European Eye Epidemiology Consortium (E3) and from clinic-based bio-banks, to validate currently known genetic and non-genetic risk factors for age-related macular degeneration (AMD). It will also investigate their interaction, test and interpret their pathophysiological consequences at the molecular level, and establish individualized risk profiles according to the different subgroups of AMD patients.

More information



BMF publications in the EYE.RISK project:

  • Monés, J., Garcia, M., Biarnés, M., Lakkaraju, A., & Ferraro, L. (2017). Drusen Ooze: A Novel Hypothesis in Geographic Atrophy. Ophthalmology Retina.
  • Monés, J., & Biarnés, M. (2017). Geographic atrophy phenotype identification by cluster analysis. British Journal of Ophthalmology, bjophthalmol-2017.

For more information you can access to the project in ResearchGate.

BMF carries out a program of clinical trials for researching new treatments for vision diseases. Contact us! You could be the patient we’re looking for.

I want to take part in the clinical trials